Evidence map›Paper›PMID 41102453›Full record

ArticleNature metabolism2025

Interaction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuel.

Anna K Greda, Jemila P Gomes, Vanessa Schmidt-Krueger, Ewa Zurawska-Plaksej, Raphaela Fritsche-Guenther, Ina-Maria Rudolph, Narasimha S Telugu, Cagla Cömert, Jennifer Kirwan, Séverine Kunz and 5 more

Abstract read
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Neurons run on fat.npj metabolic health and disease · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Phenotypic diversity of frontotemporal lobar degeneration in two novel GRN variants from Colombia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anna K Greda *Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Jemila P Gomes *Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Vanessa Schmidt-KruegerMolecular Cardiovascular Research, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0002-5851-1087
Ewa Zurawska-PlaksejMolecular Cardiovascular Research, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Raphaela Fritsche-GuentherBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Metabolomics, Berlin, Germany.
Ina-Maria RudolphMolecular Cardiovascular Research, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0002-3903-0755
Narasimha S TeluguTechnology Platform for Pluripotent Stem Cells, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Cagla CömertDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Jennifer KirwanBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Metabolomics, Berlin, Germany.ORCID http://orcid.org/0000-0002-5423-1651
Séverine KunzTechnology Platform for Electron Microscopy, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0002-0131-3506
Michael RotheLipidomix GmbH, Berlin, Germany.
Mogens JohannsenDepartment of Forensic Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-2548-7025
Sebastian DieckeTechnology Platform for Pluripotent Stem Cells, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0002-5219-5992
Peter BrossDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9526-8525
Thomas E WillnowDepartment of Biomedicine, Aarhus University, Aarhus, Denmark. tew@biomed.au.dk.ORCID http://orcid.org/0000-0001-9515-7921

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sortilin (SORT1) is a lipoprotein receptor that shows genome-wide association with hypercholesterolaemia, explained by its ability to control hepatic output of lipoproteins. Although SORT1 also shows genome-wide association with Alzheimer disease and frontotemporal lobe dementia, the most prevalent forms of age-related dementias, sortilin's contribution to human brain lipid metabolism and health remains unclear. Here we show that sortilin mediates neuronal uptake of polyunsaturated fatty acids carried by apolipoprotein E (apoE). Using humanized mouse strains and induced pluripotent stem cell-based cell models of brain lipid homeostasis, we demonstrate that internalized lipids are converted into ligands for peroxisome proliferator-activated receptor alpha inducing transcription profiles that enable neurons to use long-chain fatty acids as metabolic fuel when glucose is limited. This pathway works with apoE3 but cannot operate with the Alzheimer disease risk factor apoE4, which disrupts sortilin's endocytic activity. Our data indicate a role for the lipoprotein receptor sortilin in metabolic fuel choice in neurons, which may be crucial when glucose supply is limited, such as in the ageing brain.

Indexed as

Adaptor Proteins, Vesicular TransportApolipoprotein E3Fatty AcidsNeuronsAnimalsBrainHumansInduced Pluripotent Stem CellsLipid MetabolismMiceSortilinAdaptor Proteins, Vesicular TransportApolipoprotein E3Fatty AcidsSortilin

Identifiers

PMID41102453
PMCPMC12638250

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.